Biological manufacturer Novozymes and chemical/seed giant Syngenta, have announced a global marketing and distribution agreement for Novozymes’s microbial-based biofungicide Taegro, a microbial-based fungicide based on the naturally occurring Bacillus subtilis bacterium.
Novozymes says Taegro targets fungal diseases such as rhizoctonia and fusarium on fruit and vegetables, and its application is expected to be expanded to a wider portfolio of crops such as wheat, soy and corn.
The two companies will work together to bring Taegro to market. Syngenta will be responsible for sales, marketing and distribution, while Novozymes will be responsible for production and registration.
In a release, Novozymes said trials are planned to secure data to continue to build on the current U.S. registration in other regions, following which the two companies aim for a global rollout.